Morning Overview on MSN
A UK-led trial just beat bowel cancer into remission with nine weeks of pembrolizumab — and nearly three years later not one patient has seen the tumor …
Thirty-two people walked into a London hospital with operable bowel cancer. They received nine weeks of a single ...
Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/DICER1 Registry We developed and analyzed a functional Low-pass ...
The initial idea behind the study came from patients with rectal cancer, and we saw that a proportion of patients with mismatch repair deficient (MMRd) tumors did not do well with standard therapy ...
When Vanessa was diagnosed with advanced colon cancer in 2014, just before her 60th birthday, the mother and grandmother learned the cancer had already spread to her stomach and liver. Even after a ...
A new deep learning algorithm can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from ...
or on the link below. Immune checkpoint inhibitors (ICIs) are shown to be effective among patients with metastatic colorectal cancer (mCRC) harboring high microsatellite instability (MSI-H) and/or ...
Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results